Table 1

Clinical characteristics of the 192 episodes of febrile neutropenia

Clinical characteristicEpisode
Mean age (years)53.5 (SD 12.4)
Gender (male/female)70/122
Underlying cancer, N (%)
    Breast cancer65 (33.9%)
    Haematological cancer59 (30.7%)
    Pulmonary cancer24 (12.5%)
    Gastrointestinal cancer23 (12.0%)
    Skeletal cancer6 (3.1%)
    Hepatobiliary cancer3 (1.6%)
    Other solid tumour12 (6.3%)
Comorbidity, N (%)
    Recent surgery (<6 months)46 (24.0%)
    Previous neutropenic fever47 (24.5%)
    Diabetes mellitus19 (9.9%)
    Heart failure5 (2.6%)
Prophylactic medication, N (%)
    Antibiotic medication24 (12.5)
    Antifungal medication6 (3.1%)
Central venous catheter in place, N (%)11 (5.7%)
First installed chemotherapy, N (%)61 (31.8%)
Latency after chemotherapy <7 days, N (%)41 (24%)
Duration of fever at presentation <24 h, N (%)135 (70.3%)
Presumed site of infection at presentation, N (%)
    Gastrointestinal tract65 (33.9%)
    Unexplained fever62 (32.3%)
    Pulmonary tract44 (22.9%)
    Other21 (10.9%)